XML 64 R53.htm IDEA: XBRL DOCUMENT v3.21.1
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
3 Months Ended
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Mar. 31, 2021
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance $ 841 $ 767  
Changes in estimated fair value (13) 33  
Payments 0 (106)  
Other (12) 0  
Fair value, ending balance 816 694  
Current liability     $ 285
Contingent consideration 816 $ 694 816
Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Fair value, beginning balance 711    
Fair value, ending balance 697    
Contingent consideration $ 711   $ 697
Contingent consideration, measurement input, discount rate (as percent)     0.115
Measurement Input, Discount Rate | Sanofi Pasteur      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Contingent consideration, measurement input, discount rate (as percent)     0.08